Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer s Life and Analytical Sciences Revenue Slides 8 Percent in Q4; Coggins to Retire

NEW YORK, Jan. 27 (GenomeWeb News) - PerkinElmer yesterday said that revenue for its Life and Analytical Sciences business unit declined 8 percent to $286.5 million for the fourth quarter of 2005.


The company attributed the decline to the "longer fiscal period in 2004 versus this year." 


PerkinElmer posted total fourth-quarter 2005 revenue of $387.7 million, a 6-percent decrease over $411.6 million in the fourth quarter of 2004.


PerkinElmer spent $21 million on R&D during the fourth quarter of 2005, down from $22.3 million in the comparable period of 2004.


The company reported net income of $187.8 million, or $1.45, versus $37.9 million, or $.29 per share in the fourth quarter of 2004. The company said fourth quarter earnings include net divestiture gains of $1.47 per share.


As GenomeWeb News reported in October, PerkinElmer divested its aerospace and fluid-testing businesses during the quarter. Its semiconductor unit is expected to be spun off in the first quarter.


As of Jan. 1, PerkinElmer had cash and cash equivalents of $502.3 million.


Separately today, the company said Robert Friel would replace Peter Coggins as president of the Life and Analytical Sciences unit. Friel joined the company in 1999 and previously served as executive vice president and chief financial officer for the company. Coggins will retire in February.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.